The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort

BACKGROUND: Cerebrospinal fluid (CSF) analysis for detecting amyloid positivity may be as reliable as positron emission tomography (PET). We evaluated the performance of the amyloid beta (Aβ)42/40 ratio for predicting amyloid positivity by PET, compared with Aβ42 alone, and phosphorylated tau 181 (p...

Descripción completa

Detalles Bibliográficos
Autores principales: Amft, Michaela, Ortner, Marion, Eichenlaub, Udo, Goldhardt, Oliver, Diehl-Schmid, Janine, Hedderich, Dennis M., Yakushev, Igor, Grimmer, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044878/
https://www.ncbi.nlm.nih.gov/pubmed/35473631
http://dx.doi.org/10.1186/s13195-022-01003-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044878/
https://www.ncbi.nlm.nih.gov/pubmed/35473631
http://dx.doi.org/10.1186/s13195-022-01003-w

Ejemplares similares